Regulatory Expectations for RCT Designs – Clinical Trial Design and Protocol Development
Randomized Controlled Trials (RCTs) are fundamental in the clinical research sector, offering a robust method for evaluating the efficacy and safety of new medical interventions. However, the design and execution of these trials must adhere to certain regulatory expectations to ensure reliable and ethically sound results. This tutorial provides an overview of these regulatory expectations, focusing on the principles that underpin good clinical practice and the roles of various stakeholders such as the USFDA.
Click to read the full article.